Igor Fischer

Heinrich Heine University Düsseldorf

Papers

1

Total Citations

16

H-Index

1

About

Igor Fischer’s research lies at the intersection of neuro-oncology, stem cell biology, and automated drug discovery. His most cited work, “Robot technology identifies a Parkinsonian therapeutics repurpose to target stem cells of glioblastoma” (2020, 16 citations), exemplifies his innovative approach: using a robotic workstation to screen existing drugs for new applications against glioblastoma stem cells. This study identified a Parkinson’s disease therapeutic as a potential repurposed treatment, directly addressing the clinical need for therapies targeting the stem-cell hierarchy that drives this lethal brain tumor. Fischer’s work is notable for its methodological rigor—combining high-throughput automation with a deep understanding of the neurotransmitter microenvironment—and its translational impact, offering a faster path to clinical testing. His contributions highlight how interdisciplinary strategies can uncover hidden vulnerabilities in cancer, making his research a valuable resource for students and scientists exploring drug repurposing, cancer stem cell biology, or the integration of robotics into biomedical discovery.

Research Focus

Key Achievements

1
H-Index
1
Papers
16
Total Citations
16
Avg Citations/Paper
🏆 Most Cited Paper
Robot technology identifies a Parkinsonian therapeutics repurpose to target stem cells of glioblastoma
16 citations · 2020
📈 Most Prolific Year: 2020 (1 Papers)
🤝 Key Collaborators: 10
🏛 Institutions: Heinrich Heine University Düsseldorf

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago